Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.

Item
http://www.wikidata.org/entity/Q33495912
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.Caspofungin as secondary antifungal prophylaxis and subsequent maintenance antifungal prophylaxis therapy in hematological malignancy patients.Use of antifungal drugs in hematologyBreakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin.Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.Invasive aspergillosis in children with acquired immunodeficiencies.Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.Analysis of the efficiency and costs of antifungal prophylaxis and mycological diagnostics in patients undergoing allogeneic haematopoietic cell transplantation: "real life" evaluation.Nanosuspension formulation of itraconazole eliminates the negative inotropic effect of SPORANOX in dogs.The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis.Current role of echinocandins in the management of invasive aspergillosis.
P2860

Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.

Item
http://www.wikidata.org/entity/Q33495912
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
name
Efficacy of caspofungin and it ...... a multinational case registry.
@ast
Efficacy of caspofungin and it ...... a multinational case registry.
@en
type
label
Efficacy of caspofungin and it ...... a multinational case registry.
@ast
Efficacy of caspofungin and it ...... a multinational case registry.
@en
prefLabel
Efficacy of caspofungin and it ...... a multinational case registry.
@ast
Efficacy of caspofungin and it ...... a multinational case registry.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Efficacy of caspofungin and it ...... a multinational case registry.
@en
P2093
P304
P31
P356
10.1016/J.IJANTIMICAG.2009.06.025
P433
P478
P50
P577
P5875
P698